Marked improvement of renal failure and severe hypertension after renal artery stenting in the solitary functioning kidney  by Sawai, Toshiki et al.
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a  b  s  t  r  a  c  t
Atherosclerotic  renal  artery  stenosis  (ARAS)  can  cause  resistant  hypertension,  progressive  renal  failure
and/or  cardiorenal  syndrome.  Although  no  randomized  study  to  demonstrate  the  superiority  of  renal
stenting  over  medical  treatment  is  available,  a case-sensitive  approach  is required  for  the  treatment  of
ARAS.  Here,  we  describe  a case  report  of  a symptomatic  ARAS  patient  with  a solitary  functioning  kidneyeywords:
enovascular hypertension
eripheral vascular disease
hronic renal insufﬁciency
enal artery stenting
in which  successful  detection  of ARAS  by ultrasonography  examination  with  the  Doppler  method  and
timely  renal  artery  stenting  were  performed.
<Learning  objective:  The  clinical  efﬁcacy  of  renal  artery  stenting  for  symptomatic  ARAS  as  a  method
of  lowering  blood  pressure  and preventing  deterioration  in  renal  function  remains  unproven.  However,
renal  artery  stenting  performed  based  on  enough  investigation  of clinical  course  and information  by
ultrasonography  examination  with  Doppler  method  results  in beneﬁt  to the  patient  with  ARAS.>
©  2012  Japanese  College  of Cardiology.  Published  by  Elsevier  Ltd.  All rights  reserved.ntroduction
Renovascular hypertension due to atherosclerotic renal artery
tenosis (ARAS) is a major cause of secondary hypertension, and
s often severe or resistant to treatment. This hypertension is pro-
ressive and causes ischemic nephropathy or renal failure [1].  The
TAR and ASTRAL trials, which compared drug treatment and revas-
ularization, showed no superiority of revascularization to drug
reatment in terms of the preservation of renal function, blood pres-
ure control, and effects on cardiovascular events [2,3]. However,
hese studies involved limitations regarding patient enrollments.
hus, a case-sensitive approach is required for the treatment of
RAS. There have been many studies on factors predicting the
ffects of revascularization [4–7]. We  report an ARAS patient with a
olitary functioning kidney that was successfully detected by ultra-
onography examination with the Doppler method and who was
reated by renal artery stenting.∗ Corresponding author. Tel.: +81 59 231 5015; fax: +81 59 231 5201.
E-mail address: tsawai@clin.medic.mie-u.ac.jp (T. Sawai).
878-5409/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jccase.2012.12.001Case report
A 57-year-old female with past history of coronary angioplasty
had been treated for hypertension for 10 years, but its control had
been poor. In December 2009, she was  admitted to our hospital
due to acute heart failure by cardiorenal syndrome. The serum cre-
atinine level was  1.3 mg/dl [estimated glomerular ﬁltration rate
(eGFR): 33.7 ml/min/1.73 m2]. For the poorly controlled hyperten-
sion, three antihypertensive agents, nifedipine CR (40 mg/day),
cilnidipine (10 mg/day), and valsartan (80 mg/day), were adminis-
tered, but her blood pressure remained at 160–170/80–90 mmHg.
Secondary hypertension was  suspected for her refractory hyper-
tension, and various examinations were performed. Plasma renin
activity was 4 ng/ml/h (normal range: 0.8–2.0 ng/ml/h) and aldos-
terone concentration was  105 pg/ml (normal range: 30–160 pg/ml).
Renal artery ultrasonography examination with the Doppler
method revealed the atrophic left kidney with complete obstruc-
tion of the renal artery. In the right kidney, ultrasonography
examination with the Doppler method revealed that the peak
systolic velocity was 204 cm/s, renal to aortic ratio was 3.6, and
acceleration time was  120 ms,  and these measured values that
increased suggested severe stenosis of right renal artery. The resis-
tive index was  normal (0.65). Renograms showed that the left
kidney was non-functional kidney and the function of right kidney
vier Ltd. All rights reserved.
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Fig. 2. Blood pressure dramatically improved after renal artery revascularization.
PTRA, percutaneous transluminal renal angioplasty; SBP, systolic blood pressure;
DBP, diastolic blood pressure.T. Sawai et al. / Journal of Ca
ecreased. She was discharged after having been treated for heart
ailure, and treated with the above anti-hypertensive drugs at an
utpatient clinic. However, her blood pressure control remained
oor, and the serum creatinine level began to gradually increase in
ay  2010, reaching 2.39 mg/dl in July. Since uremia developed, she
as admitted on July 14, 2010 again.
On admission, her blood pressure was 201/100 mmHg, and
he serum creatinine level increased to 3.21 mg/dl (eGFR:
2.5 ml/min/1.73 m2). B-type natriuretic peptide (BNP) level was
50 pg/ml. On July 21, selective renal artery angiography showed
 severe stenotic lesion from the ostium to the middle portion of
he right renal artery (Fig. 1A). A Palmaz Genesis 4.0 mm × 18 mm
tent (Cordis Corp., Bridgewater, NJ, USA) was  deployed after
re-dilatation (Fig. 1B). A device for distal protection was not
sed, however, there were no complications such as peripheral
mbolism, and only 20 ml  of contrast agent were used.
The preoperative urine volume was 400–500 ml/day, which
arkedly increased immediately after the revascularization
o 2500 ml/day. The systolic blood pressure decreased to
00–130 mmHg  the next day (Fig. 2). The serum creatinine level
ecreased to 2.07 mg/dl after 1 week. Although the doses of the
nti-hypertensive drugs could not be reduced, the systolic blood
ressure measured at the outpatient clinic became stable in the
ange of 130–140 mmHg. The serum creatinine level continued to
radually improve after discharge, and decreased to 1.09 mg/dl in
ecember 2010, 5 months after the revascularization (Fig. 3).
iscussion
In this patient, there were the following 4 important points:
1) Renal artery stenting resulted in marked improvement in renal
unction and blood pressure. (2) Despite the presence of renal artery
tenosis, the values of renin activity and aldosterone were almost
n the normal range. (3) On the evaluation for renal artery stenosis
nd the prediction of the effects of revascularization, renal artery
ltrasonography examination with the Doppler method was  useful.
4) Renal artery stenting was performed in this case with a solitary
unctioning kidney.
mprovement in renal function and blood pressure
Many previous reports showed that 8–51% of patients who
nderwent renal artery revascularization were categorized as hav-
ng improved renal function and up to 31% had worsened renal
unction [8],  therefore improvement in renal function by renal
rtery revascularization has been controversial. We  will discuss
Fig. 1. (A) Pre-procedural right renal artery angiogram. White arrow shows the sevFig. 3. Serum creatinine level dramatically improved after renal artery revasculari-
zation. PTRA, percutaneous transluminal renal angioplasty.
factors predicting an improvement in renal function below. With
regard to blood pressure, there are several reports that an anti-
hypertensive effect of renal artery revascularization is achieved in
many cases [9],  and that pre-interventional BNP and translesional
pressure gradient may  be helpful to identify patients in whom renal
angioplasty will improve blood pressure [10,11]. However, it is dif-
ﬁcult to get complete normalization of blood pressure, and in this
case, the doses of the anti-hypertensive drugs could not be reduced.
ere stenosis. (B) Angiogram after stenting. White bar shows implanted stent.
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valuation for renin activity and aldosterone
Generally, renin activity in the peripheral blood should be
ncreased in renovascular hypertension. However, in this case, since
enal blood ﬂow was markedly decreased due to complete obstruc-
ion of the left renal artery and severe stenosis in the right renal
rtery, the main cause of hypertension observed before renal angio-
lasty may  have been a volume overload. The renin–angiotensin
ystem before renal angioplasty may  have been rather inhibited
ecause of negative feedback by volume overload, resulting in no
ncrease in these measurements. Therefore, values of renin activity
nd aldosterone may  not be related to indication of renal angio-
lasty. With increase of urine output after renal angioplasty, her
ody weight decreased by 5 kg in 1 week. Plasma renin activity was
.5 ng/ml/h and aldosterone concentration was 282 pg/ml 1 week
fter renal angioplasty.
sefulness of ultrasonography examination with Doppler method
nd prediction of renal function improvement
For the detection of renal artery stenosis, both the sensitivity
nd the speciﬁcity of contrast computed tomography are more
han 90% [12]. However, in patients such as this one with renal
ysfunction, this method is difﬁcult because of concern about
ontrast-induced nephropathy. Renal artery ultrasonography
xamination with the Doppler method is noninvasive and useful
or morphological and functional diagnosis, and should be actively
erformed in patients with suspected renal artery stenosis.
his method is also recommended by American Heart Associa-
ion/American College of Cardiology (AHA/ACC) guidelines [13].
n addition to the diagnostic usefulness, this provides important
nformation on whether the preserving effects of renal angioplasty
an be expected. Based on various previous studies [4–7], in the
resence of the following factors, renal angioplasty is expected
o exert preserving effects on the renal function: (1) proteinuria,
1 g/day; (2) creatinine level, <3.0–4.0 mg/dl; (3) progressive renal
ysfunction; (4) absence of renal atrophy (long axis ≥ 7 cm); and (5)
esistive index of the interlobar artery, <0.8. The latter two  factors
an be evaluated by ultrasonography. In this patient, the preoper-
tive serum creatinine level was high (3.21 mg/dl), but proteinuria
as absent, and progressive renal dysfunction was observed. In
ddition, ultrasonography showed the absence of right kidney
trophy and a resistive index of the interlobar artery of 0.65. These
ndings suggested that the renal function can be improved by renal
ngioplasty. However, there is a report that a resistive index is not
 predictor of improvement of renal function [14], and we should
ecide the utility of resistive index depending on an individual
ase.
enal artery stenting in case with a solitary functioning kidney
This case presented with a solitary functioning kidney, there-
ore, if complications occurred at renal angioplasty, severe renal
ailure may  have occurred. However, Davies et al. reported that
enal artery stenting can be performed safely when the con-
ralateral kidney is not only normal but also non-functional [15].
n particular, with the appearance of renal artery stents, this
echnique has been reported to be superior to balloon dilata-
ion alone in terms of both the success and the restenosis rates
16].
Previous randomized studies [9,17,18] included patients treated
y only balloon dilatation as well as patients treated by stent
mplantation, therefore, superiority of stent implantation over
edical treatment alone were not evaluated precisely. However,
fter detailed evaluation of the clinical background and ﬁndings of
ltrasonography examination with the Doppler method, patients in
[gy Cases 7 (2013) e82–e85
whom renal artery stenting is indicated can be selected. AHA/ACC
guidelines highly recommended renal stenting for symptomatic
ARAS with a solitary functioning kidney [13].
In this case, elevation of plasma renin activity and aldosterone
concentration after renal angioplasty was revealed. Some previ-
ous reports showed that renin and aldosterone were secreted even
by an atrophied kidney, and renal venous blood sampling could
be used as a predictive test for revascularization or surgically cor-
rectable renal disease when the ischemic and atrophied kidney has
a signiﬁcantly higher venous plasma renin activity than the nor-
mal  kidney [19–21].  When blood pressure control becomes difﬁcult
using drug administration alone, an increase in renin secretion
should be conﬁrmed by renal venous blood sampling, and revascu-
larization of the completely obstructed renal artery or nephrectomy
should be considered. Nagata et al. reported a patient in whom
an increase in renin secretion from an atrophied kidney was con-
ﬁrmed, and revascularization for a completely obstructed renal
artery succeeded, achieving favorable blood pressure control [20].
Conclusion
This case reported the successful management of an ARAS
patient with a solitary functioning kidney. Besides early identiﬁ-
cation of ARAS by ultrasonography examination with the Doppler
method, timely renal artery stenting tailored to the patient could
contribute to clinical success.
Disclosures
None.
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